Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
about
Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular SystemIdentification of early biomarkers during acetaminophen-induced hepatotoxicity by fourier transform infrared microspectroscopyImpairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis.Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsyDynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapyViral myocarditis: from experimental models to molecular diagnosis in patients.Regulation of the immune response during infectious myocarditis.Myocyte signalling in leucocyte recruitment to the heart.Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.In vitro activity of Paris polyphylla smith against enterovirus 71 and coxsackievirus B3 and its immune modulation.Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy.Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy.Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.MyocarditisSilencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis
P2860
Q26774063-345B4E80-B0FE-41BD-ACFB-84DEA3430C01Q28483876-2515A699-F6BC-4268-83F8-5DB0D4482210Q34016246-7FEB8328-C627-4931-B7B0-09A05D8FB084Q34345561-0129DF42-91C0-4A62-A28A-E9D2DF54BEA1Q35597574-B7A09C34-7511-4A5B-BAFA-76B0E241FFA2Q35854730-04C178A6-6482-4E8F-B584-A545841BFEC3Q36232271-CF32BB40-2786-446F-AEE3-43370E557AC7Q38052447-E1B51D4F-44E1-4BC8-9BF6-CF2297DE9188Q38180743-05B3B328-E4EE-47A4-B2B0-4945A26BA153Q38185647-4E2CEDC9-1AE0-40A5-BC09-025FD6344A87Q39208267-78196676-42C2-4F1D-8DCB-ADB639EF76D8Q39443002-2396842E-0411-48F5-809C-DCBB3631E812Q41846142-568D9541-B33C-41C7-AD32-329149A0021CQ42220469-4F2C99B5-4773-4EB3-9329-27E00B170A48Q42267231-BAA33EDD-98A7-433C-9595-4E9E73D97A9DQ42592117-7781B88E-E07E-44D5-B171-A6B4F71FE454Q56933171-F9971C0F-BDA6-48D6-88F5-D7F638F7C7CCQ57817469-E9C4FDD2-DB78-419E-BAE8-8158334751D4
P2860
Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Sustained nitric oxide synthes ...... e to interleukin-10 disorders.
@en
type
label
Sustained nitric oxide synthes ...... e to interleukin-10 disorders.
@en
prefLabel
Sustained nitric oxide synthes ...... e to interleukin-10 disorders.
@en
P2093
P2860
P50
P1476
Sustained nitric oxide synthes ...... e to interleukin-10 disorders.
@en
P2093
Andreas Weinzierl
Gudrun Szalay
Joachim Hald
P2860
P304
P356
10.2353/AJPATH.2006.060350
P407
P577
2006-12-01T00:00:00Z